Floatz logo

Therapeutic Asset Ratings

427 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PEGFILGRASTIM
Prostate Cancer
Rahul AggarwalP2B (56)
Pyruvate
Prostate Cancer
Ivan de Kouchkovsky, MDP2B (56)
TRASTUZUMAB
Prostate Cancer
Mayo ClinicP2B (56)
Rapamycin
Prostate Cancer
Medical University of South CarolinaP2/3B (56)
VIPIVOTIDE TETRAXETAN GALLIUM GA-68
Prostate Cancer
University of WashingtonP2/3B (56)
Oxycodone
Prostate Cancer
Deventer ZiekenhuisP4CCC (55)
Atezolizumab
Prostate Cancer
ExelixisP3CCC (55)
Gdc-0068
Prostate Cancer
Hoffmann-La RocheP2CCC (55)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Prostate Cancer
Mayo ClinicP2CCC (55)
Gadopiclenol
Prostate Cancer
Columbia UniversityP4CCC (54)
Oxygen
Prostate Cancer
Beth Israel Deaconess Medical CenterP4CCC (54)
Polyethylene Glycol 3350
Prostate Cancer
Chad R. TracyP4CCC (54)
Semaglutide
Prostate Cancer
Hamilton Health Sciences CorporationP4CCC (54)
SUFENTANYL
Prostate Cancer
RenJi HospitalP4CCC (54)
68Ga-NYM032
Prostate Cancer
Norroy Bioscience Co., LTDP3CCC (54)
aaa817
Prostate Cancer
Novartis PharmaceuticalsP3CCC (54)
Adv-Tk
Prostate Cancer
Candel Therapeutics, Inc.P3CCC (54)
Alpha Tocopherol
Prostate Cancer
University of NebraskaP3CCC (54)
INR101
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., LtdP3CCC (54)
Satraplatin
Prostate Cancer
Shanghai Jiao Tong University School of MedicineP3CCC (54)
Valaciclovir
Prostate Cancer
Candel Therapeutics, Inc.P3CCC (54)
FLUDEOXYGLUCOSE
Prostate Cancer
University of Wisconsin, MadisonP2CCC (54)
PSMA I&T
Prostate Cancer
CHU de Quebec-Universite LavalP2CCC (54)
Ptvg-Ar
Prostate Cancer
University of Wisconsin, MadisonP2CCC (54)
CHOLINE C-11 ION
Prostate Cancer
Peking University Cancer Hospital & InstituteP2CCC (53)
Showing 101 to 125 of 427 assets
PreviousPage 5 of 18Next